Distsinct requirements for C-C chemokine and IL-2 production by naive, previously activated, and anergic T cells

Journal of Immunology

Volumn 164, Issue 8, 2000, Pages 3996-4002

  Lerner, Cara G ^a   Horton, Maureen R ^b   Schwartz, Ronald H ^a   Powell, Jonathan D ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CD28 ANTIGEN; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCLONAL ANTIBODY; OKT 3; CALCINEURIN; CD4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; LEUKOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; A J MOUSE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CALCIUM SIGNALING; CELL CLONE; CELL CULTURE; GENETICS; IMMUNOLOGY; INTERPHASE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PHYSIOLOGY; T LYMPHOCYTE; TH1 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD4; CALCINEURIN; CALCIUM SIGNALING; CELLS, CULTURED; CHEMOKINES, CC; CLONAL ANERGY; CLONE CELLS; INTERLEUKIN-2; INTERPHASE; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED A; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TH1 CELLS;

EID: 0034654652     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.8.3996     Document Type: Article

References (48)

1. Boussiotis, V. A., G. J. Freeman, G. Gray, J. Gribben, and L. M. Nadler. 1993. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J. Exp. Med. 178: 1753.
2. Davis, S. J., and P. A. van der Merwe. 1996. The structure and ligand interactions of CD2: implications for T-cell function, Immunol. Today 17:177.
3. Powell, J. D., C. G. Lerner, and R. H. Schwartz. 1999. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J. Immunol. 162:2775.
4. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1.
5. Schwartz, R. H. 1997. T cell clonal anergy. Curr. Opin. Immunol. 9:351.
6. Beverly, B., S. M. Kang, M. J. Lenardo, and R. H. Schwartz. 1992 Reversal of in vitro T cell clonal anergy by 1L-2 stimulation. Int. Immunol. 4:661.
7. Jenkins, M. K., C. A. Chen, G. Jung, D. L. Mueller, and R. H. Schwartz. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 114:16.
8. Cook, D. N. 1996. The role of MIP-1α in inflammation and hematopoiesis. J. Leukocyte Biol. 59:61.
9. Rollins, B. J. 1997. Chemokines. Blood 90:909.
10. Schall, T. J., and K. B. Bacon. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6:865.
11. Taub, D. D. 1996. Chemokine-leukocyte interactions: the voodoo that they do so well. Cytokine Growth Factor Rev. 7:355.
12. Karpus, W. J., N. W. Lukacs, K. J. Kennedy, W. S. Smith, S. D. Hurst, and T. A. Barrett. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158:4129.
13. Taub, D. D., J. R. Ortaldo, S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. β Chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukocyte Biol. 59:81.
14. Taub, D. D., S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. Chemokines and T lymphocyte activation. 1. β Chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:2095.
15. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269:1727.
16. Herold, K. C., J. Lu, I. Rulifson, V. Vezys, D. Taub, M. J. Grusby, and J. A. Bluestone. 1997. Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J. Immunol. 159:4150.
17. Riley, J. L., R. G. Carroll, B. L. Levine, W. Bernstein, D. C. St. Louis, O. S Weislow, and C. H. June. 1997. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J. Immunol. 158:5545.
18. Staruch, M. J., R. Camacho, and F. J. Dumont. 1998. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1α. MIP-1β, and RANTES vs IL-2 and TNF-α by activated human T cells. Cell Immunol 190:121.
19. Beverly, B., K. Brorson, S. Umlauf, and R. H. Schwartz. 1993. Technology to study gene transcription in normal T lymphocyte clones. In Methods in Molecular Genetics. K. Adolph, ed. Academic Press, Orlando, FL, p. 331.
20. Kubo, R. T., W. Born, J. W. Kappler, P. Marrack, and M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol. 142:2736.
21. Gross, J. A., T. St. John, and J. P. Allison. 1990. The murine homologue of the T lymphocyte antigen CD28: Molecular cloning and cell surface expression. J. Immunol. 144:3201.
22. Ashwell, J. D., R. E. Cunningham, P. D. Noguchi, and D. Hernandez. 1987. Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165:173.
23. Kitagawa-Sakakida, S., and R. H. Schwartz. 1996. Multifactor cis-dominant negative regulation of IL-2 gene expression in anergized T cells. J. Immunol. 157: 2328.
24. Horton, M. R., M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. 1998. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J. Immunol. 160:3023.
25. Powell, J. D., C. G. Lerner, G. R. Ewoldt, and R. H. Schwartz. 1999. The - 180 Site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. J. Immunol. 163:6631.
26. Schena, M., D. Shalon, R. W. Davis, and P. O. Brown. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467.
27. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259.
28. Zipfel, P. F., J. Balke, S. G. Irving, K. Kelly, and U. Siebenlist. 1989. Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors. J. Immunol. 142:1582.
29. + T-cell clones by cyclosporin A. J. Neuroimmunol. 76:91.
30. Widmer, U., Z. Yang, S. van Deventer, K. R. Manogue, B. Sherry, and A. Cerami. 1991. Genomic structure of murine macrophage inflammatory protein-1 alpha and conservation of potential regulatory sequences with a human homolog, LD78. J. Immunol. 146:4031.
31. Widmer, U., K. R. Manogue, A. Cerami, and B. Sherry. 1993. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1α, and MIP-1β, members of the chemokine superfamily of proinflammatory cytokines. J. Immunol. 150:4996.
32. Griscavage, J. M., S. Wilk, and L. J. Ignarro. 1996. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB. Proc. Natl. Acad. Sci. USA 93:3308.
33. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
34. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54:1.
35. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
36. Powell, J. D., J. A. Ragheb, S. Kitagawa-Sakakida, and R. H. Schwartz. 1998. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol. Rev. 165:287.
37. Viola, A., S. Schroeder, Y. Sakakibara, and A. Lanzavecchia. 1999. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283:680.
38. Lafferty, K. J., and A. J. Cunningham. 1975. A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 53:27.
39. + T cells. Science 271:1272.
40. + T cells. Science 271:1276.
41. Godiska, R., D. Chantry, G. N. Dietsch, and P. W. Gray. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:167.
42. Miyagishi, R., S. Kikuchi, C. Takayama, Y. Inoue, and K. Tashiro. 1997. Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J. Neuroimmunol. 77:17.
43. Kennedy, K. J., R. M. Stricter, S. L. Kunkel, N. W. Lukacs, and W. J. Karpus. 1998. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1. J. Neuroimmunol. 92:98.
44. Bradley, L. M., V. C. Asensio, L. K. Schioetz, J. Harbertson, T. Krahl, G. Patstone, N. Woolf, I. L. Campbell, and N. Sarvetnick. 1999. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162:2511.
45. van Deventer, S. J. 1997. Review article: chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease? Aliment. Pharmacol. Ther. 11(Suppl. 3):116.
46. McDonald, S. A., M. J. Palmen, E. P. Van Rees, and T. T. MacDonald. 1997. Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunology 91:73.
47. Frasca, L., P. Carmichael, R. Lechler, and G. Lombardi. 1997. Anergic T cells effect linked suppression. Eur. J. Immunol. 27:3191.
48. Taams, L. S., A. J. van Rensen, M. C. Poelen, C. A. van Els, A. C. Besseling, J. P. Wagenaar, W. van Eden, and M. H. Wauben. 1998. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur J. Immunol. 28:2902.